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Many medicines and devices used for the
healthcare of children are unlicensed and
untested for use in paediatrics, and clini-
cians often have to rely on evidence in
adults that may not be generalisable to
children.1 2 There are a number of
reasons why evidence in adults cannot
always be safely extrapolated to children,
including different pharmacokinetic and
pharmacodynamic processes, and drug
safety and efﬁcacy being dependent on
stage of development. Growing recogni-
tion of these issues has led to initiatives to
increase the number of paediatric trials.3
In addition, recognition of the important
differences in design and interpretation of
trials conducted in adults and children—
including ethical issues, validity of out-
comes, age-speciﬁc and developmental
stage-speciﬁc harms and confounders—
has highlighted deﬁciencies in the quality
of paediatric trial conduct and reporting
and prompted repeated calls for child-
speciﬁc reporting guidelines.4
Reporting guidelines such as
Consolidated Standards Of Reporting
Trials (CONSORT) and STrengthening the
Reporting of OBservational studies in
Epidemiology (STROBE) aim to improve
transparency, allowing identiﬁcation of
potential biases, critical assessments of
robustness and replication in different set-
tings.5 6 Many leading journals actively
endorse reporting guidelines and refer
authors to the Enhancing the QUAlity
and Transparency Of health Research
(EQUATOR) Network website (http://www.
equator-network.org). The EQUATOR
Network was established to improve the
reliability and usability of health research
literature by facilitating accurate and com-
plete reporting of research studies.7
Despite the comprehensive collection of
existing resources and reporting guidelines
available on the EQUATOR website, there
has been a lack of guidance for the report-
ing of paediatric studies until now.8
Aiming to ﬁll this gap, and in response to
the need to improve quality in reporting
of paediatric research, several child-
speciﬁc extensions to established guide-
lines are under development, including
for CONSORT, Standard Protocol Items
for Randomised Trials (SPIRIT) and
Preferred Reporting Items for Systematic
reviews and Meta-analysis (PRISMA).5 8–10
These initiatives will complement
previous guidelines by recommending
consideration of paediatric-speciﬁc issues,
including choice of appropriate outcomes,
stratiﬁcation by age or development,
dosing or formulation, safety and ethical
considerations. For example, detailed
reporting of the age distribution of study
participants is vital for understanding out-
comes, treatment effects and potential
effects of growth and maturation; report-
ing the validity of outcome measures in
paediatric populations is also important,
as valid outcomes for adult populations
may not be relevant across childhood.11
Reporting long-term safety outcomes is
also required in situations where harms
may appear later on in development.
The most informative reporting guide-
lines are underpinned by robust methodo-
logical development, typically through
establishing consensus from experts and
stakeholders in an iterative process of
feedback and review. However, providing
robust evidence about the impact of
guidelines on quality of reporting is chal-
lenging.12 13 The list of 320 reporting
guidelines currently published on the
EQUATOR website is continuing to grow
(as of July 2016), and while some argue
that these checklists represent another
hurdle to publication, others recognise that
any tool to improve the quality and trans-
parency of research reports can only
increase the likelihood of manuscript
acceptance.14 In addition to supporting
authors in producing accurate and transpar-
ent representations of their research, report-
ing checklists are also a valuable aid for peer
reviewers assessing the quality of studies
submitted for publication.15 Despite the
well-recognised shortcomings of peer
review, including inevitable inconsistencies,
limited capacity to identify all errors or
weaknesses and potential reviewer biases,
the current system is a crucial component of
scientiﬁc research publication. Encouraging
the use of reporting checklists can help to
improve the process and support reviewers
in providing quality reviews.16
Journals implement reporting guide-
lines in various ways, but commonly refer
to relevant reporting guidelines in their
Instructions to Authors. Some journals
have explicit philosophies of transparency,
accuracy and completeness in reporting.
For example, the BMJ journal group’s
‘Transparency Policy’ requests that authors
follow complete reporting checklists prior
to submission (http://www.bmj.com/about-
bmj/resources-authors/forms-policies-and-
checklists/transparency-policy). For Archives
of Disease in Childhood, as for other BMJ
journals, authors are referred to the
EQUATOR Network website and encour-
aged to use appropriate guidelines to
“ensure that you provide enough informa-
tion for editors, peer reviewers and
readers to understand how the research
was performed and to judge whether the
ﬁndings are likely to be reliable”. Other
journals, such as PLoS Medicine, require
authors to submit appropriate checklists
alongside their manuscript or to provide
an explanation if no relevant guideline
exists.
Given the challenges in conducting ran-
domised trials in children, observational
studies based on population-based admin-
istrative data sources are increasingly
being used to provide evidence and
support quality improvement for paediat-
rics. Administrative or electronic health
data sources contain individual-level
records primarily collected for reasons
other than research (eg, ﬁnancial or
clinical management) and can provide
rich, detailed information on patient path-
ways.17 However, there are unique chal-
lenges for the analysis of such data.18
Administrative data do not always contain
the complete, accurate information that
researchers require. For example, a study
of children with and without diabetes
requires accurate classiﬁcation of the
disease, which is reliant on (i) the clinician
recognising the diagnosis, (ii) the diagno-
sis being recorded in clinical notes, (iii)
medical coders correctly coding the diag-
nosis and (iv) researchers including the
correct codes in their analysis. Omissions
in any of these steps could lead to missing
information, which could in turn lead to
bias. Transparency of reporting is there-
fore key to producing valid and reliable
research based on administrative data. The
REporting of studies Conducted using
Observational Routinely-collected health
Data (RECORD) initiative aims to comple-
ment the STROBE guidelines by providing
guidance on issues relating speciﬁcally to
administrative data, including the use of
data linkage, access and availability of data
and code list validation.19 For example,
RECORD recommends that algorithms or
codes used to identify the study population,
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exposures, outcomes and other variables are
listed in detail; that any ﬁltering based on
data quality, data availability or linkage
should be described and that the implica-
tions of using data not collected speciﬁcally
for research should be discussed.19
Positive public perception of paediatric
research is crucial, both in facilitating
recruitment of children into trials and in
exploiting existing data sources for child
health research. Both authors and journals
have an important role to play in support-
ing the public in making informed deci-
sions about the use of their data, through
maintaining a high level of transparency
and quality in reporting of paediatric
health research. The use of reporting
guidelines by authors and reviewers can
aid careful interpretation of ﬁndings and
enable those working in health policy to
make evidence-based decisions on paediat-
ric care and health systems.
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